Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131.2 USD | +0.37% | +4.31% | +20.34% |
Apr. 26 | Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141 | MT |
Apr. 26 | Morgan Stanley Adjusts Merck & Co.'s Price Target to $132 From $128 | MT |
Official Publications
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 10Q-1 | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
Annual ESG Report | CO | |
SEC Filing 10K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
Dividends | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
Slide show half-year results | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Official Publications